SEGALL BRYANT & HAMILL, LLC - FURIEX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
SEGALL BRYANT & HAMILL, LLC ownership history of FURIEX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$2,689,000
-40.5%
25,326
-51.2%
0.06%
+18.5%
Q1 2014$4,518,000
+105.6%
51,938
-0.7%
0.05%
+107.7%
Q4 2013$2,198,000
+90.0%
52,330
+99.0%
0.03%
-10.3%
Q3 2013$1,157,000
+29.3%
26,298
+0.1%
0.03%
+20.8%
Q2 2013$895,000
-9.2%
26,269
-0.1%
0.02%
-7.7%
Q1 2013$986,00026,2940.03%
Other shareholders
FURIEX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 349,356$15,368,00010.66%
Consonance Capital Management LP 761,764$33,510,0008.38%
Global Alpha Capital Management Ltd. 66,974$3,028,0004.92%
Breithorn Capital Management 59,158$2,602,0001.52%
Artal Group S.A. 971,051$42,717,0001.39%
Montibus Capital Management LLC 190,286$8,370,681,0000.90%
THOMPSON SIEGEL & WALMSLEY LLC 551,606$24,265,0000.53%
FRANKLIN STREET ADVISORS INC /NC 43,950$1,933,0000.43%
AMERICAN CAPITAL MANAGEMENT INC 49,392$2,173,0000.29%
Spark Investment Management LLC 28,200$1,240,0000.28%
View complete list of FURIEX PHARMACEUTICALS INC shareholders